9 Meters Biopharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
46.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.82
|
-0.72
|
0.10
|
12.20%
|
|
2022-06-30
|
-0.83
|
-0.80
|
0.03
|
3.61%
|
|
2022-03-31
|
-0.75
|
-0.80
|
-0.05
|
-6.67%
|
|
2021-12-31
|
-0.72
|
-0.80
|
-0.08
|
-11.11%
|
|
2021-09-30
|
-0.73
|
-1.00
|
-0.27
|
-36.99%
|
|
2021-06-30
|
-0.60
|
-0.60
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.55
|
-0.60
|
-0.05
|
-9.09%
|
|
2020-12-31
|
-0.82
|
-1.00
|
-0.18
|
-21.95%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.32
|
|
2021-12-31
|
-3.00
|
|
2020-12-31
|
-2.84
|
|
2019-12-31
|
-0.80
|
|
2018-12-31
|
-1.06
|
|
2017-12-31
|
-9.30
|
|
2016-12-31
|
-87.26
|